Vericiguat for heart failure after a heart attack
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests a medication called Vericiguat for people with heart failure and a weak heart pump after a past heart attack. It aims to see if the drug can help improve your condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a heart attack at least 3 months ago.
- Your heart failure symptoms have been stable for at least one month.
- You are 18 years or older.
- Your heart's pumping ability (ejection fraction) is 40% or less.
- A blood test shows a marker of heart strain (NT-proBNP) is at least 450 pg/mL.
- You must be willing to sign a consent form to join the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called vericiguat against standard treatments to see if it helps people with worsening heart failure. It may be an option if you have heart failure with a weak heart pump and recently needed more medical help.
This trial tests whether vericiguat can improve heart function in people with stable heart failure and a reduced pumping ability. It may help if you have not needed hospital or IV treatments for worsening heart failure in the last 6 months.
This trial tests how a medication called vericiguat works in people with both chronic kidney disease and heart failure. It aims to see if the drug helps manage these conditions together.
This trial tests if adding vericiguat to standard heart failure medicines helps people hospitalized with worsening heart failure. It's for those with a weak heart pump and high NT-proBNP levels.
This trial tests a drug called vericiguat to see if it helps people with heart failure affecting the right side of the heart and a leaky tricuspid valve. You may qualify if you have a weak right ventricle, a low pump strength in the left ventricle, and symptoms that have recently gotten worse.
This trial tests if starting vericiguat early after a heart attack helps patients with heart failure. It's for people who had a procedure to open a blocked artery and then developed heart failure within two weeks.
Hear when a new HFrEF - Heart Failure With Reduced Ejection Fraction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.